A newly funded medical device startup had successfully proven its technology concept but lacked the internal resources to navigate the complexities of Quality Management, Regulatory Affairs, and Technical Documentation. Building a robust Quality Management System (QMS) from scratch would have diverted precious time and funding from core product development. Instead, the company chose Zamann Pharma Support’s “Quality as a Service” model, which allowed them to join Zamann’s existing QMS framework within two months.
Through this approach, the startup leveraged Zamann’s MDR-compliant procedures, established infrastructure, and regulatory expertise. Costs were far lower than assembling an entire QMS independently, and the startup also shortened its product registration timelines significantly. The successful launch has led the company to maintain a close collaboration with Zamann, outsourcing the bulk of their QA and regulatory obligations to take advantage of the ongoing benefits of this unique partnership.
We guide companies through medical device and IVD EU registration by supporting MDR and IVDR requirements, technical documentation, and structured processes for compliant market access.
Startups can integrate into an established, MDR-compliant QMS instead of building their own system. Then, they use existing SOPs, templates, and documentation structures. As a result, they reduce setup time and avoid delays in product development and market entry.
Companies lower costs by outsourcing quality and regulatory functions to an experienced service provider. In addition, they avoid hiring full in-house QA teams during early growth stages. Therefore, they save budget while still maintaining full compliance with regulatory requirements.
External QMS support provides ready-to-use compliance infrastructure and expert regulatory guidance. Moreover, it reduces errors in documentation and speeds up submission preparation. Consequently, startups move through MDR approval pathways faster and reach the market earlier.